Life Science REIT PLC

Real Estate GB LABS

38.3GBP
-1.4(3.53%)

Last update at 2024-11-21T16:37:00Z

Day Range

38.0040.40

LowHigh

52 Week Range

54.4376.32

LowHigh

Fundamentals

Previous Close 39.70
Market Cap214.20M
Volume595019
P/E Ratio-
Dividend Yield6.51%
Revenue TTM19.30M
Revenue Per Share TTM0.06
Gross Profit TTM 1.28M
Diluted EPS TTM-0.08

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31
Type	yearly	yearly
Date	2022-12-31	2021-12-31
Income before tax	-27.46700M	7.74M
Minority interest	-	-
Net income	-27.61300M	7.74M
Selling general administrative	7.55M	0.38M
Selling and marketing expenses	-	-
Gross profit	-19.92000M	8.12M
Reconciled depreciation	-	-
Ebit	5.33M	-0.72480M
Ebitda	-27.46700M	7.74M
Depreciation and amortization	-	-
Non operating income net other	-	-
Operating income	-27.46700M	7.74M
Other operating expenses	7.55M	0.38M
Interest expense	3.78M	0.00000M
Tax provision	0.15M	0.00000M
Interest income	3.25M	0.00700M
Net interest income	-0.52700M	0.00700M
Extraordinary items	-	-
Non recurring	-	-
Other items	-	-
Income tax expense	0.15M	-
Total revenue	-19.92000M	8.12M
Total operating expenses	7.55M	0.38M
Cost of revenue	-	-
Total other income expense net	-	-
Discontinued operations	-	-
Net income from continuing ops	-27.61300M	7.74M
Net income applicable to common shares	-	18.58M
Preferred stock and other adjustments	-	-

Breakdown	2022-12-31	2021-12-31
Type	yearly	yearly
Date	2022-12-31	2021-12-31
Total assets	447.82M	361.40M
Intangible assets	-	-
Earning assets	-	-
Other current assets	4.00M	1.39M
Total liab	128.37M	10.82M
Total stockholder equity	319.45M	350.58M
Deferred long term liab	-	-
Other current liab	-1.02700M	9.31M
Common stock	3.50M	3.50M
Capital stock	3.50M	3.50M
Retained earnings	-19.87200M	7.74M
Other liab	-	-
Good will	-	-
Other assets	422.55M	-
Cash	10.61M	165.96M
Cash and equivalents	-	-
Total current liabilities	1.03M	10.82M
Current deferred revenue	-	-
Net debt	99.22M	-165.96200M
Short term debt	-	-
Short long term debt	-	-
Short long term debt total	109.83M	-
Other stockholder equity	335.82M	339.34M
Property plant equipment	-	192.17M
Total current assets	20.97M	166.94M
Long term investments	4.30M	-
Net tangible assets	-	350.58M
Short term investments	-	-
Net receivables	10.37M	0.98M
Long term debt	-	-
Inventory	-	-
Accounts payable	1.03M	-
Total permanent equity	-	-
Noncontrolling interest in consolidated entity	-	-
Temporary equity redeemable noncontrolling interests	-	-
Accumulated other comprehensive income	-	-
Additional paid in capital	-	-
Common stock total equity	-	-
Preferred stock total equity	-	-
Retained earnings total equity	-	-
Treasury stock	-	-
Accumulated amortization	-	-
Non currrent assets other	-4.30300M	-
Deferred long term asset charges	-	-
Non current assets total	4.30M	-
Capital lease obligations	-	-
Long term debt total	-	-

Breakdown	2022-12-31	2021-12-31
Type	yearly	yearly
Date	2022-12-31	2021-12-31
Investments	-186.37800M	-181.51700M
Change to liabilities	0.00000M	0.00000M
Total cashflows from investing activities	-	-435.64080M
Net borrowings	-	-
Total cash from financing activities	67.11M	343.94M
Change to operating activities	-	17.02M
Net income	-26.94000M	7.73M
Change in cash	-120.35600M	165.96M
Begin period cash flow	165.96M	0.00000M
End period cash flow	45.61M	165.96M
Total cash from operating activities	-1.08800M	3.54M
Issuance of capital stock	0.00000M	350.00M
Depreciation	-	-
Other cashflows from investing activities	-	0.02M
Dividends paid	3.50M	0.00000M
Change to inventory	-	-
Change to account receivables	-	-7.60560M
Sale purchase of stock	-	-
Other cashflows from financing activities	96.87M	-6.05900M
Change to netincome	-	-19.50000M
Capital expenditures	7.64M	7.64M
Change receivables	-	-
Cash flows other operating	-	-
Exchange rate changes	-	-
Cash and cash equivalents changes	-	-
Change in working capital	-5.46000M	3.92M
Stock based compensation	-	-
Other non cash items	31.31M	-8.11800M
Free cash flow	-1.08800M	3.54M

Peer Comparison

Sector: Real Estate Industry: REIT - Healthcare Facilities

Company	Change (GBP)	Price (GBP)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)
LABS Life Science REIT PLC	-1.4 3.53%	38.30	-	-	37.01	0.69
AGR Assura PLC	- -%	38.32	-	12.95	9.40	0.91	16.89	-18.2888
PHP Primary Health Properties	- -%	93.00	-	14.84	8.81	0.92	70.21
THRL Target Healthcare REIT Ltd	-0.8 0.95%	83.50	-	14.35	7.47	0.82	5.13	26.25

Reports Covered

View All

Key Executives

Name	Title	Year Born
Mr. Simon Farnsworth	Managing Director	NA
Tamara Deering	Head of Financial Planning & Reporting	NA
Mr. David Lewis	Director of Operations & Fin.	NA
Ms. Stephanie Adams	Legal Counsel	NA
Dr. Sally Ann Forsyth O.B.E., Ph.D.	Independent Non-Exec. Director & Sustainability Lead	NA
Mr. Ian Harris	Director of Asset Management	NA
Ms. Pippa Stacey	Head of ESG & Consultant	NA
Daniel Williams	Corp. & Devel. Financial Controller	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.